Page last updated: 2024-11-03

procarbazine and Cancer of the Retina

procarbazine has been researched along with Cancer of the Retina in 2 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klimova, A1
Heissigerova, J1
Rihova, E1
Brichova, M1
Pytlik, R1
Spicka, I1
Mrazova, K1
Karolova, J1
Svozilkova, P1
Pe'er, J1
Rowe, JM1
Frenkel, S1
Dann, EJ1

Other Studies

2 other studies available for procarbazine and Cancer of the Retina

ArticleYear
Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
    The British journal of ophthalmology, 2018, Volume: 102, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Eye Neoplasms; Female;

2018
Testicular lymphoma, intraocular (vitreoretinal) lymphoma, and brain lymphoma: involvement of three immunoprivileged sites in one patient.
    American journal of hematology, 2010, Volume: 85, Issue:8

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2010